{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-041884","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2023-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.149569+00:00","generated_at":"2026-06-08T00:25:41.681193+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ZyVersa receives Nasdaq delisting determination over low bid price; hearing requested","bullets":["Nasdaq determined to delist on Nov 16, but company requested hearing, staying delisting pending panel decision.","Stock closed at $0.10 or less for 10 consecutive days, triggering Low Priced Stocks Rule.","Company had until Dec 6, 2023 to regain $1.00 bid compliance; low price accelerated delisting.","Stockholders approved reverse stock split (1:10-1:50) at Oct 31 meeting; may be used to regain compliance.","No assurance of favorable hearing outcome or extension; stock continues trading under ZVSA."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-041884","json":"https://secwatch.observer/filing/0001493152-23-041884.json","markdown":"https://secwatch.observer/filing/0001493152-23-041884.md","text":"https://secwatch.observer/filing/0001493152-23-041884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/0001493152-23-041884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T00:25:41.681193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00a504f38bd0a64ac731e023921ec346bd00314d","claim":"ZyVersa Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)(iii)).","evidence_excerpt":"November 14, 2023, Nasdaq issued a letter to the Company that as of November 13, 2023, it determined that the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As a result, Nasdaq has determined to delist the Company’s securities from The Nasdaq Global Market, on November 16, 2023, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). Accordingly, the Company has timely reque","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/0001493152-23-041884-index.htm","confidence":0.99,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1), 5810(c)(3)(A)(iii)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}